A bank that decides a client is too regulatory-risky to hold deposits does not typically stay warm to the idea of underwriting their IPO. The fact that JPMorgan has done exactly that tells you more about where prediction markets are going than any single regulatory filing this year.
The Financial Times reported that JPMorgan terminated Polymarket's banking relationship over regulatory concerns, but has left the door open to underwriting a potential public offering. Polymarket has not filed to go public and has not announced an IPO. What it has done is seek to raise more than a billion dollars at a valuation that would make an eventual listing worth chasing.
The separation of "too risky to bank" from "too lucrative to ignore" is not a new posture for large financial institutions. I have watched this pattern run in other sectors — a compliance department drawing one line while an investment banking division quietly stands behind a different one. The two positions are internally consistent if you accept the underlying logic: deposit-taking creates a continuous, auditable relationship that a regulator can act on at any moment, while underwriting fees arrive once, at closing, from a company that will by then be someone else's public-market problem.
What makes this specific case worth watching is the regulatory backdrop it sits inside. The CFTC is moving toward formalising rules on prediction markets. Kalshi is fighting simultaneous orders from the same federal regulator and a state judge in Washington who told it to stop. Connecticut has added its own challenge. Polymarket, which operates with a different structure and a user base that skews international, has referred over ninety accounts to authorities on potential insider trading this year alone. The sector is generating both growth numbers and compliance headlines at a pace that does not usually coexist this comfortably.
JPMorgan's read, if the FT's reporting is accurate, is that the compliance risk lives in the banking relationship and not in the IPO advisory one. That is a precise legal judgment, and it is probably correct as a matter of current regulatory exposure. It is less clearly correct as a matter of where the CFTC lands in twelve months.
The consensus view is that JPMorgan's posture reflects institutional caution — a bank being careful in a novel space. I think it reflects something sharper: a bank that has already decided prediction markets reach public scale, and has positioned itself to be in the room when they do, at the only moment in the lifecycle when the regulatory risk belongs entirely to the new shareholders.
